These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 12618237

  • 1. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.
    Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T.
    Cardiovasc Res; 2003 Mar; 57(3):757-65. PubMed ID: 12618237
    [Abstract] [Full Text] [Related]

  • 2. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure.
    Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Miwa T, Hori M, Masuyama T.
    Hypertension; 2004 Mar; 43(3):686-91. PubMed ID: 14757777
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of angiotensin-converting enzyme inhibition on sarcoplasmic reticulum function in the failing heart of the Dahl rat.
    Satoh S, Ueda Y, Suematsu N, Oyama J, Kadokami T, Sugano M, Yoshikawa Y, Makino N.
    Circ J; 2003 Aug; 67(8):705-11. PubMed ID: 12890915
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix.
    Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Nakayama H, Otsu K, Suzuki K, Tada M, Hori M, Miwa T, Masuyama T.
    J Hypertens; 2003 Sep; 21(9):1737-45. PubMed ID: 12923407
    [Abstract] [Full Text] [Related]

  • 5. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure.
    Yamamoto K, Mano T, Yoshida J, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T.
    J Hypertens; 2005 Feb; 23(2):393-400. PubMed ID: 15662228
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M, Machida N, Mitsuishi M, Yamane Y.
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [Abstract] [Full Text] [Related]

  • 9. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure.
    Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS.
    Circulation; 1995 May 15; 91(10):2642-54. PubMed ID: 7743628
    [Abstract] [Full Text] [Related]

  • 10. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor.
    Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, Miwa T, Masuyama T.
    Circulation; 2004 May 04; 109(17):2143-9. PubMed ID: 15051632
    [Abstract] [Full Text] [Related]

  • 11. Calcium handling and sarcoplasmic-reticular protein functions during heart-failure transition in ventricular myocardium from rats with hypertension.
    Yoneda T, Kihara Y, Ohkusa T, Iwanaga Y, Inagaki K, Takeuchi Y, Hayashida W, Ueyama T, Hisamatsu Y, Fujita M, Hatac S, Matsuzaki M, Sasayama S.
    Life Sci; 2001 Nov 30; 70(2):143-57. PubMed ID: 11787940
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
    Hayashida W, Kihara Y, Yasaka A, Sasayama S.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):347-51. PubMed ID: 10873609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Rothermund L, Vetter R, Dieterich M, Kossmehl P, Gögebakan O, Yagil C, Yagil Y, Kreutz R.
    Circulation; 2002 Oct 29; 106(18):2305-8. PubMed ID: 12403658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats.
    Emoto N, Raharjo SB, Isaka D, Masuda S, Adiarto S, Jeng AY, Yokoyama M.
    Hypertension; 2005 Jun 29; 45(6):1145-52. PubMed ID: 15897363
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.